BRCA1: To test or not to test, that is the question

Singer, Mendel E.; Cebul, Randall D.
January 1997
Health Matrix: Journal of Law-Medicine;Winter97, Vol. 7 Issue 1, p163
Academic Journal
Looks at the various issues which should be considered when considering genetic screening for the breast cancer gene mutation. Decision analysis; Decision tree for BRCA1 testing; Cost of testing; Emotional impact of testing; Impact of test results on subsequent compliance; Prophylactic mastectomy; Genetic discrimination.


Related Articles

  • A public health perspective on the control of predictive screening for breast cancer. Cunningham, George C. // Health Matrix: Journal of Law-Medicine;Winter97, Vol. 7 Issue 1, p31 

    Details the role of government public health agencies in managing genetic testing for hereditary breast cancer. Assurance that screening tests satisfy reasonable criteria as the first step; Development of a reliable screening test; Employment of legal means to limit the offering of...

  • How are Jewish women different from all other women? Press, Nancy; Burke, Wylie // Health Matrix: Journal of Law-Medicine;Winter97, Vol. 7 Issue 1, p135 

    Explores cultural attitudes toward issues which is believed to comprise much of the context into which genetic susceptibility testing for breast cancer for Ashkenazi women will emerge. Social construction of cancer and cancer phobia; Attitudes toward science in general and genetic testing in...

  • Poster presentations: 1. Clinical Genetics/Counselling.  // Journal of Medical Genetics;Sep2002 Supplement, Vol. 39, pS37 

    Discusses the abstract of the research paper entitled 'Screening for familial breast cancer--have we got it right?,' by Robert Pears, V. Mudray et al and presented during the British Human Genetics Conference at the University of York in England in September 2002.

  • Argumentation and risk communication about genetic testing: Challenges for healthcare consumers and implications for computer systems. Green, Nancy L. // Journal of Argumentation in Context;Jan2012, Vol. 1 Issue 1, p113 

    As genetic testing for the presence of potentially health-affecting mutations becomes available for more genetic conditions, many people will soon be faced with the decision of whether or not to have a genetic test. Making an informed decision requires an understanding and evaluation of the...

  • Clinical implications of BRCA1 genetic testing for Ashkenazi-Jewish women. Wiesner, Georgia L. // Health Matrix: Journal of Law-Medicine;Winter97, Vol. 7 Issue 1, p3 

    Provides a framework for understanding the impact of genetic testing for breast cancer risk in Ashkenazi-Jewish women. Scientific basis for cancer susceptibility testing; Essential concepts of inheritance and the genetics of breast cancer; Clinical implications of germline mutations for breast...

  • Jewish theological and moral reflections on genetic screening: The case of BRCA1. Dorff, Elliot N. // Health Matrix: Journal of Law-Medicine;Winter97, Vol. 7 Issue 1, p65 

    Discusses the issues surrounding the breast cancer gene from a Jewish theological and moral point of view. Medicine in Judaism in general; Review and evaluation of rabbinic responses to genetic diseases; Formulation of a Jewish response to the discovery of the gene.

  • Predisposición genética para el cáncer de mama: genes BRCA1 y BRCA2. Narod, Steven A; Rodríguez, Adriana A // Salud Pública de México;sep/oct2011, Vol. 53 Issue 5, p420 

    The discovery of genes BRCA1 and BRCA2 has led to the introduction of genetic tests more complex every time for the evaluation of the hereditary cancer risk, among others. In the present paper we explore the criteria to decide when to run the testing for the genes, as well as the implications...

  • Ontario maternal serum screening program: Practices, knowledge and opinions of health care... Carroll, June C.; Reid, Anthony J. // CMAJ: Canadian Medical Association Journal;03/15/97, Vol. 156 Issue 6, p775 

    Highlights the results of a cross-sectional self-reported survey to determine the practices, knowledge and opinions of health care providers regarding a prenatal genetic screening program in Ontario. Options for testing; Consistency of responses; Early identification of abnormalities; Increased...

  • A consumer charter for genomic services. Ledley, Fred // Nature Biotechnology;Aug2002, Vol. 20 Issue 8, p767 

    Discusses principles that are required for the move to a consumer-focused model for genetic services. Need to provide consumers with reliable sources of information that describe specific genetic tests as well as actions they could take in response to a test result; Informed consent; Generation...


Read the Article

Other Topics